O'Neill and Srinivasan head to Trump Tower, but Gottlieb has not been eliminated.
President-elect Donald Trump interviewed what appear to be two unconventional candidates for FDA commissioner, but at least one other potential selection remains among those that could receive the nomination.
The transition team indicated that Trump met with Jim O'Neill, managing director of Mithril Capital Management, and Balaji Srinivasan, partner...
George Tidmarsh has extensive experience in the biopharmaceutical industry and lead several drugs to FDA approval.
Testimony during a July 21 ‘expert panel’ could help justify stronger warnings across the class about potential adverse effects on mother and baby. Panelists ranged from clinicians who said depression during pregnancy should be treated, to those who said sadness has been “medicalized."
The long-time industry executive led several drug approvals but may have a lot to learn about the intimate details of application review and the Center for Drug Evaluation and Research.
Pink Sheet reporter and editors discuss CBER Director Vinay Prasad using an unproven theory to help explain his COVID-19 vaccine decisions and the impact of the recently finalized reduction-in-force at the FDA.
